Similar articles

• Spinal cord repair in MS: does mitochondrial metabolism play a role?

  Ciccarelli O, Altmann DR, McLean MA, Wheeler-Kingshott CA, Wimpey K, Miller DH, Thompson AJ. Ciccarelli O, et al. Neurology. 2010 Mar 2;74(9):721-7. doi: 10.1212/WNL.0b013e3181d26968. Epub 2010 Jan 27. Neurology. 2010. PMID: 20107138 Free PMC article.
• A multicenter assessment of cervical cord atrophy among MS clinical phenotypes.

  Rocca MA, Horsfield MA, Sala S, Copetti M, Valsasina P, Mesaros S, Martinelli V, Caputo D, Stosic-Opincal T, Drulovic J, Comi G, Filippi M. Rocca MA, et al. Neurology. 2011 Jun 14;76(24):2096-102. doi: 10.1212/WNL.0b013e31821f46b8. Neurology. 2011. PMID: 21670439
• Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients.

  Bjartmar C, Kidd G, Mörk S, Rudick R, Trapp BD. Bjartmar C, et al. Ann Neurol. 2000 Dec;48(6):893-901. Ann Neurol. 2000. PMID: 11117546
• Proton MR spectroscopy in multiple sclerosis.

  Arnold DL, De Stefano N, Narayanan S, Matthews PM. Arnold DL, et al. Neuroimaging Clin N Am. 2000 Nov;10(4):789-98 ,ix-x. Neuroimaging Clin N Am. 2000. PMID: 11359725 Review.
• The use of modern magnetic resonance techniques to monitor disease evolution in multiple sclerosis.

  Filippi M, Rocca MA. Filippi M, et al. Adv Neurol. 2006;98:167-83. Adv Neurol. 2006. PMID: 16400834 Review. No abstract available.